volociximab also known chimeric monoclonal antibody jointly developed pdl biopharma biogen idec treatment variety advanced solid tumors binds inhibits functional activity thought reduce metastases early results show potential renal cell cancerscitation needed monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikivolociximab